Aldrich Laboratory
Innovation in Anti-Tuberculosis Drug Discovery
The Aldrich Group believes that diversity, equity and inclusion are important cornerstones in scientific research.
We are actively continuing to build a diversified lab environment that creates a positive work culture, encourages collaboration and creativity. We strongly encourage individuals from historically marginalized communities to join our group.
Infectious Disease
Mycobacterium tuberculosis is the leading cause of infectious disease mortality with 10 million people falling ill and almost 1.6 million patients dying.
Chemical Biology
The Aldrich group uses interdisciplinary techniques to ask and answer scientific questions.
Drug Discovery
Our group looks into rational drug design of novel antibiotics for multi-drug resistant mycobacteria and the biosynthesis of natural compounds.
